Riverside’s private equity portfolio

Portfolio

Return to Portfolio Search

GTI Diagnostics

GTI Diagnostics develops, manufactures and markets specialty test kits for the in vitro diagnostics industry. Its advanced proprietary products fulfill niche testing needs and are used in over 400 laboratories. GTI is an ISO-certified company and registered with the FDA as an In Vitro Diagnostic Manufacturer.

Exit Summary
2.6x gross cash-on-cash; 46% gross IRR

Acquired:
July 2008
Exited:
December 2010
Industry:
Healthcare , Manufacturing
Region:
North America
Location:
Waukesha, Wisconsin
Fund:
Riverside Micro-Cap Fund ( I )
Website:
http://www.gtidiagnostics.com/
News Releases:
Riverside's Latest Acquisition Flows Smoothly
Riverside Sells In Vitro Diagnostics Company